Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors von Ludikhuize, Marlies C., Gevers, Sira, Nguyen, Nguyen T. B., Meerlo, Maaike, Roudbari, S. Khadijeh Shafiei, Gulersonmez, M. Can, Stigter, Edwin C. A., Drost, Jarno, Clevers, Hans, Burgering, Boudewijn M. T., Rodríguez Colman, Maria J.

Volltext

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRAS G12D glycolytic colorectal tumors von Ludikhuize, Marlies C, Gevers, Sira, Nguyen, Nguyen T B, Meerlo, Maaike, Roudbari, S Khadijeh Shafiei, Gulersonmez, M Can, Stigter, Edwin C A, Drost, Jarno, Clevers, Hans, Burgering, Boudewijn M T, Rodríguez Colman, Maria J

Volltext

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRAS G12D glycolytic colorectal tumors von Ludikhuize, Marlies C, Gevers, Sira, Nguyen, Nguyen T.B, Meerlo, Maaike, Roudbari, S. Khadijeh Shafiei, Gulersonmez, M. Can, Stigter, Edwin C.A, Drost, Jarno, Clevers, Hans, Burgering, Boudewijn M.T, Rodríguez Colman, Maria J

Volltext

Crosstalk between E2F1 and P53 transcription factors in doxorubicin‐induced DNA damage: evidence for preventive/protective effects of silymarin von Shafiei‐Roudbari, Seyedeh‐Khadijeh, Malekinejad, Hassan, Janbaz‐Aciabar, Hamed, Razi, Mazdak

Volltext